Pyrrolidinyl Synthetic Cathinones α-PHP and 4F-α-PVP Metabolite Profiling Using Human Hepatocyte Incubations.

4F-α-PVP PV7 bath salt hepatocyte metabolism liquid chromatography–high resolution tandem mass spectrometry novel psychoactive substance synthetic cathinone α-PHP

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
28 Dec 2020
Historique:
received: 01 01 1970
revised: 24 12 2020
accepted: 25 12 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 11 9 2021
Statut: epublish

Résumé

For more than ten years, new synthetic cathinones (SCs) mimicking the effects of controlled cocaine-like stimulants have flooded the illegal drug market, causing numerous intoxications and fatalities. There are often no data on the pharmacokinetics of these substances when they first emerge onto the market. However, the detection of SC metabolites is often critical in order to prove consumption in clinical and forensic settings. In this research, the metabolite profile of two pyrrolidinyl SCs, α-pyrrolidinohexaphenone (α-PHP) and 4''-fluoro-α-pyrrolidinovalerophenone (4F-α-PVP), were characterized to identify optimal intake markers. Experiments were conducted using pooled human hepatocyte incubations followed by liquid chromatography-high-resolution tandem mass spectrometry and data-mining software. We suggest α-PHP dihydroxy-pyrrolidinyl, α-PHP hexanol, α-PHP 2'-keto-pyrrolidinyl-hexanol, and α-PHP 2'-keto-pyrrolidinyl as markers of α-PHP use, and 4F-α-PVP dihydroxy-pyrrolidinyl, 4F-α-PVP hexanol, 4F-α-PVP 2'-keto-pyrrolidinyl-hexanol, and 4F-α-PVP 2'-keto-pyrrolidinyl as markers of 4F-α-PVP use. These results represent the first data available on 4F-α-PVP metabolism. The metabolic fate of α-PHP was previously studied using human liver microsomes and urine samples from α-PHP users. We identified an additional major metabolite (α-PHP dihydroxy-pyrrolidinyl) that might be crucial for documenting exposure to α-PHP. Further experiments with suitable analytical standards, which are yet to be synthesized, and authentic specimens should be conducted to confirm these results.

Identifiants

pubmed: 33379373
pii: ijms22010230
doi: 10.3390/ijms22010230
pmc: PMC7796222
pii:
doi:

Substances chimiques

Alkaloids 0
Pyrrolidines 0
alpha-pyrrolidinohexanophenone 0
alpha-pyrrolidinovalerophenone 0
cathinone 540EI4406J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health
ID : -
Organisme : Presidency of the Ministers Council, Department of Antidrug Policy
ID : F75J18000390005

Références

Drug Test Anal. 2016 Aug;8(8):779-91
pubmed: 26331297
Drug Test Anal. 2017 May;9(5):680-698
pubmed: 27448631
Drug Test Anal. 2017 Aug;9(8):1162-1171
pubmed: 27863142
Ther Drug Monit. 2020 Apr;42(2):205-221
pubmed: 31809406
Eur Rev Med Pharmacol Sci. 2018 Jan;22(1):268-274
pubmed: 29364498
Drug Test Anal. 2018 Jan 4;:
pubmed: 29314710
Forensic Sci Int. 2013 Sep 10;231(1-3):296-9
pubmed: 23890652
Pharmacol Rev. 2005 Mar;57(1):79-115
pubmed: 15734728
AAPS J. 2017 Mar;19(2):568-577
pubmed: 28070717
Forensic Sci Int. 2019 May;298:115-120
pubmed: 30897447
Clin Pharmacol Ther. 2017 Feb;101(2):239-253
pubmed: 27727455
Bioanalysis. 2016;8(1):65-82
pubmed: 26648097
Forensic Toxicol. 2017 Jan;35(1):20-32
pubmed: 28286577
Anal Bioanal Chem. 2016 Jul;408(18):4845-56
pubmed: 27185540
J Anal Toxicol. 2016 Jan-Feb;40(1):1-11
pubmed: 26294756
Clin Chem. 2017 Nov;63(11):1753-1763
pubmed: 28821542
J Mass Spectrom. 2012 Feb;47(2):253-62
pubmed: 22359337
Clin Toxicol (Phila). 2019 Feb;57(2):112-116
pubmed: 30117325
Curr Neuropharmacol. 2017 Jul;15(5):682-691
pubmed: 29403341
Ther Drug Monit. 2020 Aug 31;:
pubmed: 32881779
Forensic Toxicol. 2016;34:61-75
pubmed: 26793277
Forensic Sci Int. 2015 Apr;249:181-8
pubmed: 25703013
J Anal Toxicol. 2019 Jan 1;43(1):e1-e6
pubmed: 30060126
Curr Drug Metab. 2000 Dec;1(4):357-89
pubmed: 11465044
Clin Chem. 2017 May;63(5):1008-1021
pubmed: 28302730
Anal Chem. 2015 Nov 3;87(21):10935-41
pubmed: 26434689
J Mass Spectrom. 2009 Jun;44(6):952-64
pubmed: 19241365
J Pharm Biomed Anal. 2018 Aug 5;157:27-35
pubmed: 29754040
J Pharmacol Exp Ther. 2016 Jan;356(1):182-90
pubmed: 26645638
J Med Chem. 1970 May;13(3):497-503
pubmed: 5441133
Drug Metab Rev. 2018 May;50(2):125-139
pubmed: 29540067
Forensic Sci Int. 2014 Oct;243:1-13
pubmed: 24769262
J Mass Spectrom. 2015 Nov;50(11):1305-17
pubmed: 26505776
Front Pharmacol. 2019 Apr 24;10:438
pubmed: 31068823
Forensic Toxicol. 2018;36(2):486-497
pubmed: 29963212
Br J Pharmacol. 2015 May;172(10):2433-44
pubmed: 25438806
Psychopharmacology (Berl). 2019 Mar;236(3):939-952
pubmed: 30397775
Front Chem. 2019 Mar 04;7:109
pubmed: 30886845
Arch Toxicol. 2020 Apr;94(4):1085-1133
pubmed: 32249347
Forensic Sci Int. 2019 Aug;301:e20-e28
pubmed: 31097357
Forensic Sci Int. 2016 Feb;259:e14-9
pubmed: 26775198

Auteurs

Jeremy Carlier (J)

Chemistry & Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Department of Excellence of Biomedical Sciences and Public Health, Unit of Forensic Toxicology, Section of Legal Medicine, Marche Polytechnic University, 60126 Ancona, Italy.
Department of Anatomical, Histological, Unit of Forensic Toxicology, Section of Legal Medicine, Forensic, and Orthopedic Sciences, Sapienza University of Rome, 00198 Rome, Italy.

Xingxing Diao (X)

Chemistry & Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Raffaele Giorgetti (R)

Department of Excellence of Biomedical Sciences and Public Health, Unit of Forensic Toxicology, Section of Legal Medicine, Marche Polytechnic University, 60126 Ancona, Italy.

Francesco P Busardò (FP)

Department of Excellence of Biomedical Sciences and Public Health, Unit of Forensic Toxicology, Section of Legal Medicine, Marche Polytechnic University, 60126 Ancona, Italy.

Marilyn A Huestis (MA)

Chemistry & Drug Metabolism Section, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Institute of Emerging Health Professions, Thomas Jefferson University, PA 19107 Philadelphia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH